News
Robitussin maker Haleon has agreed to pay $4.5 million to resolve claims it advertised the product as “non-drowsy” despite containing an ingredient that could cause sleepiness, TopClassAction ...
Robitussin was at the center of a class-action complaint over its “non-drowsy” cough and cold medicines. Screengrab from Calchi, et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC ...
Lots "02177" and "02178" for Children's Robitussin Honey Cough and Chest Congestion DM (4 ounces), expiring January 2022. Lot "CL8292" for Children's Dimetapp Cold and Cough (8 ounces), expiring ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback